Search

Your search keyword '"Wever-Pinzon, O."' showing total 75 results

Search Constraints

Start Over You searched for: Author "Wever-Pinzon, O." Remove constraint Author: "Wever-Pinzon, O." Journal the journal of heart and lung transplantation Remove constraint Journal: the journal of heart and lung transplantation
75 results on '"Wever-Pinzon, O."'

Search Results

1. Rationale, Design and Patient Characteristics from The DevelopmEnt of Non-Invasive Cell-Free DNA to Supplant INvasivE Biopsy in Heart Transplantation (DEFINE-HT) Study

2. Impact of HF Etiology on the Sustainability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

Catalog

Books, media, physical & digital resources

3. Myocardial Functional Improvement is Associated with Improved HF-Related Outcomes in Patients While on Durable LVAD: An STS INTERMACS Analysis

4. Predictive Model of the Sustainability of Favorable Response After LVAD Weaning in HF Patients: A VAD Wean Registry Analysis

5. Derivation and Validation of a Multicenter Model to Identify Candidates for Advanced HF Therapies with High Potential to Achieve Post-LVAD Reverse Cardiac Remodeling

7. (488) Impaired Liver Function is Associated with Hypotension and Elevated Right Atrial Pressure but Not Depressed Cardiac Index in Chronic Heart Failure

8. Large Variation in Heart Transplant Selection Practices During the COVID-19 Pandemic

9. Multicenter-Derived Clinical Score Predicts Structural and Functional Cardiac Improvement in Chronic Heart Failure Patients Undergoing Mechanical Circulatory Support

10. Left Ventricular Assist Device-Mediated Cardiac Recovery: Impact of Diabetes Mellitus and Glycemic Control

11. Predicting Right Ventricular Failure Following Left Ventricular Assist Device Support: A Derivation-Validation Multicenter Risk Score

12. The Impact of Diabetes Mellitus and Glycemia on Myocardial Recovery

14. Improving Prediction of Acute Right Ventricular Failure in Patients Undergoing Left Ventricular Assist Devices Using Novel Comprehensive Eighteen-Segment Echocardiographic Strain Analysis

15. The Role of Non-Glycolytic Glucose Metabolism in Myocardial Recovery Following Mechanical Unloading and Circulatory Support in Chronic Heart Failure

16. Predicting Cardiac Structural and Functional Improvement Induced by Mechanical Unloading in Chronic Heart Failure: A Derivation-Validation Multicenter Study

17. Magnitude and Time Course of Left Atrial Remodeling Changes in Patients Undergoing Chronic Left Ventricular Assist Device Support

18. Clinical Framework for the Staging of Reverse Cardiac Remodeling with Mechanical Unloading and Circulatory Support

19. Global Geographical Variation in Rates of Cardiac Recovery and Left Ventricular Assist Device Explantation in Chronic Heart Failure: Insights from the International Registry for Mechanically Assisted Circulatory Support

21. Predicting Right Ventricular Failure in Chronic Heart Failure Patients Receiving Left Ventricular Assist Device

22. Reverse Myocardial Remodeling with Centrifugal versus Axial-Flow Left Ventricular Assist Device in Chronic Heart Failure Patients

23. Predicting Cardiac Recovery before Durable Left Ventricular Assist Device Implantation in Advanced Heart Failure Patients

24. Stability of Cardiac Function after Left Ventricular Assist Device Weaning in End-Stage Heart Failure

25. Distinct Heart Failure Phenotypes Identified by Myocardial Transcriptome Sequencing: Targets for Reverse Remodeling

26. Cardiac Reverse Remodeling and Recovery in Dilated Cardiomyopathy Medication-Naive Patients Requiring Durable Left Ventricular Assist Device Support

27. Early and Late Right Heart Failure Following LVAD Implantation: Epidemiology, Natural History and Outcomes. An Analysis of the STS INTERMACS Database

28. Predictors of Favorable Outcome in Patients Bridged to Transplant with Temporary Mechanical Circulatory Support Devices

29. A Novel Predictive Risk Score for Gastrointestinal Bleed Following Implantation of Continuous Flow Left Ventricular Assist Device

30. Impact of a Novel Shared Healthcare Delivery Model in Remotely Located Patients with Left Ventricular Assist Devices

31. Advanced Failing Hearts Have a Wide Range of Fibrosis Including Overlap with Nonfailing Hearts

33. Feasibility and Effectiveness of a Shock Team Approach in Refractory Cardiogenic Shock: Preliminary Results

35. Excellent Outcomes After Heart Transplantation in Stable, Highly-Sensitized Heart Transplant Recipients Using a Wait and Match Strategy

36. Unique Characteristics of Allograft Microvasculature in Patients with Severe Symptomatic Cardiac Allograft Vasculopathy

37. Cardiac Rotational Mechanics as a Predictor of Favorable Functional Response Induced by Cardiac Assist Devices in Advanced Heart Failure

38. Readmission Rates in Patients with Left Ventricular Assist Devices

39. Myocardial and End-Organ Response after Long-Term Mechanical Unloading with Continuous-Flow Left Ventricular Assist Device: Axial- Versus Centrifugal-Flow

40. Characteristics and Co-Morbidities in Heart Transplant Recipients Who Survive into Their Eighties

41. Relationship of Myocardial Fibrosis with the Potential of Mechanical Unloading to Induce Favorable Cardiac Structural and Functional Response

42. Histologic Features of Mixed Rejection in Heart Transplantation: More Than Just Cellular + Antibody-Mediated Rejection?

43. Clinical Experience with Long-Distance Transportation of Patients on Acute Mechanical Circulatory Support Devices

44. Changes in Metabolic Substrate Utilization and Pyruvate Mitochondrial Oxidation Mismatch during Mechanical Unloading of the Failing Human Heart: Implications for Cardiac Reloading and Conditioning

45. Sustainability of Pulmonary Hypertension Reversal Before and After Heart Transplantation in Patients Bridged with Continuous-Flow LVADs: Axial- vs Centrifugal-Flow

46. Association of Pre-Implant Inflammatory Profile and Functional Recovery with Chronic LVAD Unloading

48. Role of a Multidisciplinary Shock Team in the Management of Cardiogenic Shock

49. Bridging to Transplant With Fully Implantable Biventricular Assist Devices vs. Total Artificial Heart Implantation in Patients With Advanced Biventricular Failure